Evidence map›Paper›PMID 31293423›Full record

ArticleFrontiers in pharmacology2019

Development of Standard Operating Protocols for the Optimization of

Francesca Baratta, Marco Simiele, Irene Pignata, Lorenzo Ravetto Enri, Riccardo Torta, Anna De Luca, Massimo Collino, Antonio D'Avolio, Paola Brusa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmaceutics · 2022
    Article
  4. Frontiers in pharmacology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Francesca BarattaDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Marco SimieleLaboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, ASL Città Di Torino, Amedeo di Savoia Hospital, Turin, Italy.
Irene PignataDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Lorenzo Ravetto EnriDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Riccardo TortaDepartment of Neurosciences "Rita Levi Montalcini," University of Turin, Turin, Italy.
Anna De LucaUniversity Hospital "Città della Salute e della Scienza di Torino," Turin, Italy.
Massimo CollinoDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Antonio D'AvolioLaboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, ASL Città Di Torino, Amedeo di Savoia Hospital, Turin, Italy.
Paola BrusaDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
University of Turin · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITSuperconducting and other Innovative Materials and Devices Institute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under current legislation in Italy,

Indexed as

cannabidiolCannabis oildelta-9-tetrahydrocannabinolgalenic preparationsmedical Cannabisstandard operating protocols

Identifiers

PMID31293423
PMCPMC6603222
OpenAlexW2946964357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.